Every earnings call for DCAL — management tone, guidance, KPIs and promise tracking, quarter by quarter.
DCAL · 6 transcripts · Healthcare · latest Q4 FY26Revenue ₹851 cr (+19% YoY); EBITDA ₹163 cr; EBITDA Margin 19.1%. Q4 FY26 Revenue of INR 851 crores, up ~18.85% YoY.
Read full transcript & analysisRevenue ₹720 cr (+6% YoY); EBITDA ₹113 cr; EBITDA Margin 15.7%. Q3 FY26 Revenue stood at INR 720 crores, marking a 5.5% YoY growth.
Read full transcript & analysisRevenue ₹653 cr; EBITDA ₹149 cr; EBITDA Margin 22.8%. Revenue for Q2 FY26 stood at INR 652.6 crores.
Read full transcript & analysisRevenue ₹708 cr (+35% YoY); EBITDA ₹141 cr (+386% YoY); EBITDA Margin 19.9%. Total Revenue for Q1 FY26 stood at ₹708 crores, marking a 35% YoY growth from ₹523 crores in Q1 FY25.
Read full transcript & analysisRevenue (FY25) ₹2,711 cr (+4% YoY); EBITDA (FY25) ₹472 cr; EBITDA Margin (FY25) 17.4%. Full year FY25 revenue grew 3.7% to INR 2,711 crores, with Q4 FY25 revenue up 9.4% YoY.
Read full transcript & analysisRevenue ₹682 cr; EBITDA ₹141 cr (+230% YoY). Revenue for Q3 FY25 stood at INR 682 crores.
Read full transcript & analysis